Crossmark

CYP2D6-inhibiting drugs and risk of fall injuries after newly initiated antidepressant and antipsychotic therapy in a Swedish, register-based case-crossover study

Crossref DOI link: https://doi.org/10.1038/s41598-021-85022-x

Published Online: 2021-03-11

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Dahl, Marja-Liisa

Leander, Karin

Vikström, Max

Frumerie, Clara

Nordenmalm, Sofia

Möller, Jette

Söderberg-Löfdal, Karin
Funding

Funding for this research was provided by:

The Swedish Research Council (2015-02836, 521-2013-3382)

The Swedish Research Council (2015-02836, 521-2013-3382)

The Swedish Research Council (2015-02836, 521-2013-3382)

The Swedish Research Council for Health, Working Life and Welfare (2017-00751)

The Swedish Research Council for Health, Working Life and Welfare (2017-00751)

Karolinska Institute
License Information

Text and Data Mining valid from 2021-03-11

Version of Record valid from 2021-03-11
More Information

Article History

Received: 30 December 2020

Accepted: 23 February 2021

First Online: 11 March 2021

Competing interests

: The authors declare no competing interests.

Document is current

Any future updates will be listed below